Cardiologie. [Cardiology]

Détails

ID Serval
serval:BIB_E9D13BF36DA3
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Cardiologie. [Cardiology]
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Kappenberger  L., Girod  G., Schlueter  L., Berger  A., Graf  D., Fivaz-Arbane  M.
ISSN
1660-9379 (Print)
Statut éditorial
Publié
Date de publication
01/2005
Volume
1
Numéro
2
Pages
105-6, 108-11
Notes
English Abstract Journal Article --- Old month value: Jan 12
Résumé
The therapeutic acquisition to be retained for 2004 are: 1. The elderly patients with heart failure also should receive beta blocker treatment. The correction of anaemia, aggravating factor in heart failure, improves symptoms and survival of the patient. 2. It remains to prove that the treatment of sleep apnea, which seems to be an additional factor for mortality in cardiovascular diseases, is able to reduce the risk. 3. The interventions in the endocanabinoid system which regulates weight and metabolic processes might be a promising new therapeutic acquisition. 4. Prevention of coronary disease with lipid lowering drugs is still a major topic, and the trend goes the lower the better. The problems observed with Rofecoxybe and other drug interactions reminds us to be conscious when prescribing multiple drugs. 5. The implantable defibrillator seems to be a life insurance in the event of ventricular fibrillation. However, it is not so easy to identify the patient who might really benefit.
Mots-clé
Cardiovascular Diseases/etiology/prevention & control Defibrillators, Implantable *Heart Diseases/complications/etiology/therapy Heart Failure, Congestive/complications/therapy Humans Risk Factors Sleep Apnea, Obstructive/complications
Pubmed
Création de la notice
15/02/2008 11:29
Dernière modification de la notice
20/08/2019 16:12
Données d'usage